Industry Ignited Podcast

The episode contains solid, practitioner-grounded insights about OR inefficiencies (ergonomics, sterility risks, surgical time costs) and product-market fit discovery, but is padded with generic startup advice, repetitive explanations, and several softball questions that don't push the guest deeper. The core insights about why large medtech companies avoid organic development and the hospital vendor approval sales cycle friction are valuable; however, much of the runtime is spent on self-evident observations about entrepreneurship ("it takes longer and costs more") and comfortable storytelling rather than novel or counterintuitive claims.

“These HCPs become conditioned to it because the problems they deal with, they're important and urgent. So it's easy for them to overlook the friction points that may cause inefficiencies or workflow issues”

“They do not like organic product development...They generally like to see companies commercialize it, bring it to market, show traction, and then they'll purchase that company later on down the road”

The core product innovation - a motorized adjustable step stool with weight-activated wheels - is genuinely novel in its category, but the episode relies heavily on predictable startup narratives: the co-founder anecdote origin story, the pivot from licensing to building, bootstrapping constraints, and generic resilience lessons. The specific insight about large medtech companies' aversion to organic development is fresh, but most supporting arguments and frameworks are well-trodden (MVP validation, customer feedback loops, long sales cycles in healthcare). No counterintuitive claims or first-principles thinking emerges beyond the product itself.

“So one day I was on my hands and knees stacking her step stools, and she leaned over and said, I just wish I had one that went up and down. And jokingly, yeah, I said, Hey, we should start a company”

“They showed us a Gantt chart compared to ours, and they said, well, what you're gonna do in six to eight months, it would probably take us three to four years and cost a whole lot more.”

Will Crawford brings directly relevant practitioner credibility: a decade-plus in spine sales/distribution, hands-on OR experience, and active CEO/co-founder building the product in real time with clinical feedback from an actual neurosurgeon co-founder. He speaks from operational reality, not theory. However, he is an early-stage founder still in the validation/early commercialization phase (5 years in, in only 7 states, pending profitability), not a scale operator or someone who has achieved significant company milestones. His insights are grounded but not yet battle-tested at meaningful scale.

“Over the years, you start to see all these problems that are just everyday life.”

“As an industry representative, you're always finding yourself trying to add value, looking for ways to improve either a workflow or a custom instrument”

The episode includes concrete product specifications (5 inches to 13 inches height range, 12x17 inch footprint, 15-pound axial load threshold, lithium-ion battery, platinum-cured silicone) and real workflow problems (foot pedal dislodging, sterile field breach risk, trauma surgeons needing C-arm clearance). However, it lacks hard data: no numbers on adoption rates, customer satisfaction, cost savings, surgical time reduction, or financial performance. Geographic footprint is vague ("several states pending"). No pricing, no customer counts, no quantified impact on OR efficiency or surgeon ergonomics. The storytelling is specific but the business evidence is thin.

“It expands from five inches up to almost 13 inches. It has spring-loaded wheels. So when it's non-weight bearing...it'll roll when it's non-weight bearing, kind of easy as a skateboard.”

“Every time that foot pedal accidentally gets dislodged and hits the floor, it's underneath the operating table. They have to stop what they're doing, wait for the circulator to come over, crawl underneath the patient, put the pedal back on the step, and then they can begin operating again. And in the operating room, minutes matter. You know, they always talk about surgical time. It's really expensive. It's in the hundreds of dollars per minute.”

Host Leanne Aguilar asks thoughtful contextual questions and demonstrates listening (e.g., "so you saw the problems firsthand"), but rarely pushes back, challenges assumptions, or forces deeper disclosure. Questions are almost uniformly affirmative and exploratory rather than critical. She accepts the 50-year-old problem framing without questioning market size or why no competitor has solved it. She doesn't probe unit economics, churn, actual customer feedback sentiment, or competitive responses. Follow-ups are surface-level ("So yeah, rolling platforms...sounds a lot more convenient"). The conversation is warm and encouraging but lacks the friction needed to test claims or uncover unstated challenges.

“Right. Yeah, it's no joke starting a company, right? And I know a lot, a lot's involved, a lot more than people realize sometimes.”

“All right. So it's solving a lot of problems all in one, I'm hearing. So that's really cool.”